These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2363127

  • 1. Pharmacological profile of the chemically synthesized antithrombin III binding fragment of heparin (pentasaccharide) in rats.
    Hobbelen PM, van Dinther TG, Vogel GM, van Boeckel CA, Moelker HC, Meuleman DG.
    Thromb Haemost; 1990 Apr 12; 63(2):265-70. PubMed ID: 2363127
    [Abstract] [Full Text] [Related]

  • 2. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG, Hobbelen PM, Van Dinther TG, Vogel GM, Van Boeckel CA, Moelker HC.
    Semin Thromb Hemost; 1991 Apr 12; 17 Suppl 1():112-7. PubMed ID: 2068564
    [Abstract] [Full Text] [Related]

  • 3. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 12; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540).
    Petitou M, Duchaussoy P, Jaurand G, Gourvenec F, Lederman I, Strassel JM, Bârzu T, Crépon B, Hérault JP, Lormeau JC, Bernat A, Herbert JM.
    J Med Chem; 1997 May 23; 40(11):1600-7. PubMed ID: 9171870
    [Abstract] [Full Text] [Related]

  • 7. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
    Petitou M, Lormeau JC, Choay J.
    Semin Thromb Hemost; 1991 May 23; 17 Suppl 2():143-6. PubMed ID: 1948084
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP, Merton RE, Barrowcliffe TW, Thunberg L, Lindahl U.
    Thromb Haemost; 1982 Jun 28; 47(3):244-8. PubMed ID: 7112499
    [Abstract] [Full Text] [Related]

  • 11. The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model.
    Thomas DP, Merton RE, Gray E, Barrowcliffe TW.
    Thromb Haemost; 1989 Apr 25; 61(2):204-7. PubMed ID: 2546282
    [Abstract] [Full Text] [Related]

  • 12. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 25; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 13. Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities.
    Vogel GM, van Amsterdam RG, van Dinther TG, Tromp M, Meuleman DG.
    Thromb Haemost; 2000 Oct 25; 84(4):611-20. PubMed ID: 11057859
    [Abstract] [Full Text] [Related]

  • 14. SR123781A, a synthetic heparin mimetic.
    Herbert JM, Hérault JP, Bernat A, Savi P, Schaeffer P, Driguez PA, Duchaussoy P, Petitou M.
    Thromb Haemost; 2001 May 25; 85(5):852-60. PubMed ID: 11372679
    [Abstract] [Full Text] [Related]

  • 15. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 25; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y, Dol F, Caranobe C, Petitou M, Lormeau JC, Sié P, Choay J, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):295-8. PubMed ID: 2838927
    [Abstract] [Full Text] [Related]

  • 18. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M, van Boeckel CA.
    Angew Chem Int Ed Engl; 2004 Jun 14; 43(24):3118-33. PubMed ID: 15199558
    [Abstract] [Full Text] [Related]

  • 19. Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats.
    Costantini V, Deveglia R, Stabile A, Nenci GG.
    Blood Coagul Fibrinolysis; 2000 Jan 14; 11(1):7-13. PubMed ID: 10691095
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of new synthetic heparin mimetics.
    Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer P, Bono F, Petitou M, Herbert JM.
    Thromb Haemost; 2002 Jun 14; 87(6):985-9. PubMed ID: 12083506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.